NasdaqGM - Nasdaq Real Time Price USD
Sage Therapeutics, Inc. (SAGE)
6.46
-0.06
(-0.92%)
At close: May 30 at 4:00:00 PM EDT
6.46
0.00
(0.00%)
After hours: May 30 at 4:04:10 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 5 | 6 |
| Avg. Estimate | -0.94 | -0.86 | -3.61 | -3.16 |
| Low Estimate | -1.02 | -0.97 | -3.98 | -3.73 |
| High Estimate | -0.8 | -0.51 | -2.93 | -2.45 |
| Year Ago EPS | -1.7 | -1.53 | -6.23 | -3.61 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 14 | 19 | 19 |
| Avg. Estimate | 16.69M | 24.96M | 82.52M | 119.17M |
| Low Estimate | 15M | 16.43M | 62.94M | 80M |
| High Estimate | 19.6M | 72.6M | 129.9M | 189.2M |
| Year Ago Sales | 8.65M | 11.87M | 41.24M | 82.52M |
| Sales Growth (year/est) | 92.87% | 110.22% | 100.08% | 44.41% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -1.64 | -1.55 | -1.36 | -1.01 |
| EPS Actual | -1.7 | -1.53 | -1.2 | -1 |
| Difference | -0.06 | 0.02 | 0.16 | 0.02 |
| Surprise % | -3.42% | 1.32% | 11.69% | 1.53% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.94 | -0.86 | -3.61 | -3.16 |
| 7 Days Ago | -0.94 | -0.84 | -3.57 | -3.21 |
| 30 Days Ago | -0.92 | -0.82 | -3.49 | -2.49 |
| 60 Days Ago | -0.94 | -0.85 | -3.57 | -2.53 |
| 90 Days Ago | -0.93 | -0.83 | -3.67 | -2.53 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | 3 | 3 | 3 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 3 | 3 | 2 | 4 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SAGE | 44.51% | 43.75% | 42.01% | 12.67% |
| S&P 500 | 13.08% | 2.48% | 7.55% | 13.96% |
Upgrades & Downgrades
| Reiterates | Needham: Hold to Hold | 4/30/2025 |
| Reiterates | Needham: Hold to Hold | 4/25/2025 |
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 2/12/2025 |
| Reiterates | Wedbush: Neutral to Neutral | 2/12/2025 |
| Maintains | Canaccord Genuity: Hold to Hold | 2/12/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 2/12/2025 |
Related Tickers
AGIO Agios Pharmaceuticals, Inc.
32.09
+0.79%
TVTX Travere Therapeutics, Inc.
15.02
-2.34%
RARE Ultragenyx Pharmaceutical Inc.
34.03
-2.85%
ACAD ACADIA Pharmaceuticals Inc.
21.57
-3.23%
KROS Keros Therapeutics, Inc.
14.15
+0.93%
ARCT Arcturus Therapeutics Holdings Inc.
12.53
-1.57%
INCY Incyte Corporation
65.06
-1.48%
FOLD Amicus Therapeutics, Inc.
6.07
-2.25%
KRYS Krystal Biotech, Inc.
125.96
+0.28%
SNDX Syndax Pharmaceuticals, Inc.
10.54
-0.75%